The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Ardea Biosciences, Inc. In Connection With The Sale Of The Company To AstraZeneca
Levi & Korsinsky is investigating the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (Nasdaq: RDEA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AstraZeneca. Under the terms of the agreement, Ardea shareholders will receive $32 per share. The transaction has a total approximate value of $1.26 billion.
Click here to learn how to join the action: http://www.zlk.com/ardea-biosciences-rdea, or call: 877-363-5972. There is no cost or obligation to you.
The investigation concerns whether the Ardea Board of Directors breached their fiduciary duties to Ardea stockholders by failing to adequately shop the Company before entering into this transaction and whether AstraZeneca is underpaying for Ardea shares, thus unlawfully harming Ardea stockholders. In particular, at least one analyst set a price target for Ardea stock at $40.00 per share.
If you own common stock in Ardea and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or http://www.zlk.com.Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV